Therapeutic biology: checkpoint pathway activation therapy, HIV Tat, and transkingdom RNA interference - PubMed (original) (raw)
Review
. 2006 Dec;209(3):695-700.
doi: 10.1002/jcp.20817.
Affiliations
- PMID: 17001685
- DOI: 10.1002/jcp.20817
Review
Therapeutic biology: checkpoint pathway activation therapy, HIV Tat, and transkingdom RNA interference
Chiang J Li. J Cell Physiol. 2006 Dec.
Abstract
Therapeutic biology is an exciting new frontier in the post-genomic era with the mission to better human health. The explosive increase in the understanding of molecular and regulatory biology has enabled the identification of a plethora of potential targets and pathways for the discovery of new medicines. Conversely, molecularly based therapeutic intervention of biological aberrations in human diseases offers a test of the depth of our understanding of biology. This article discusses three examples of therapeutic biology research. The first concerns the treatment of cancer by activating genome surveillance circuitry, namely checkpoint-pathway activation therapy. The second example is the identification of the HIV Tat protein as both a cause of immune cell activation and apoptosis, and as a vaccine candidate against HIV infection. The third example describes transkingdom RNA interference and its application in the investigational and therapeutic silencing of disease genes.
(c) 2006 Wiley-Liss, Inc.
Similar articles
- Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
Ping YH, Chu CY, Cao H, Jacque JM, Stevenson M, Rana TM. Ping YH, et al. Retrovirology. 2004 Dec 27;1:46. doi: 10.1186/1742-4690-1-46. Retrovirology. 2004. PMID: 15620346 Free PMC article. - Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis.
Ehret A, Westendorp MO, Herr I, Debatin KM, Heeney JL, Frank R, Krammer PH. Ehret A, et al. J Virol. 1996 Sep;70(9):6502-7. doi: 10.1128/JVI.70.9.6502-6507.1996. J Virol. 1996. PMID: 8709290 Free PMC article. - Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells.
Kim N, Kukkonen S, Martinez-Viedma Mdel P, Gupta S, Aldovini A. Kim N, et al. Blood. 2013 May 16;121(20):4090-100. doi: 10.1182/blood-2012-10-461566. Epub 2013 Mar 27. Blood. 2013. PMID: 23535064 Free PMC article. - HIV-1 Tat-based vaccines: from basic science to clinical trials.
Fanales-Belasio E, Cafaro A, Cara A, Negri DR, Fiorelli V, Butto S, Moretti S, Maggiorella MT, Baroncelli S, Michelini Z, Tripiciano A, Sernicola L, Scoglio A, Borsetti A, Ridolfi B, Bona R, Ten Haaft P, Macchia I, Leone P, Pavone-Cossut MR, Nappi F, Vardas E, Magnani M, Laguardia E, Caputo A, Titti F, Ensoli B. Fanales-Belasio E, et al. DNA Cell Biol. 2002 Sep;21(9):599-610. doi: 10.1089/104454902760330138. DNA Cell Biol. 2002. PMID: 12396602 Review. - Virus-host interactions: new insights from the small RNA world.
Browne EP, Li J, Chong M, Littman DR. Browne EP, et al. Genome Biol. 2005;6(11):238. doi: 10.1186/gb-2005-6-11-238. Epub 2005 Oct 31. Genome Biol. 2005. PMID: 16277756 Free PMC article. Review.
Cited by
- Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights.
da Cruz EHG, Silvers MA, Jardim GAM, Resende JM, Cavalcanti BC, Bomfim IS, Pessoa C, de Simone CA, Botteselle GV, Braga AL, Nair DK, Namboothiri INN, Boothman DA, da Silva Júnior EN. da Cruz EHG, et al. Eur J Med Chem. 2016 Oct 21;122:1-16. doi: 10.1016/j.ejmech.2016.06.019. Epub 2016 Jun 14. Eur J Med Chem. 2016. PMID: 27341379 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources